Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,412
  • Shares Outstanding, K 16,394
  • Annual Sales, $ 24,410 K
  • Annual Income, $ 490 K
  • 60-Month Beta 0.91
  • Price/Sales 2.27
  • Price/Cash Flow 58.53
  • Price/Book 1.13
Trade SRTS with:

Options Overview Details

View History
  • Implied Volatility 132.17% ( -25.38%)
  • Historical Volatility 88.66%
  • IV Percentile 85%
  • IV Rank 48.53%
  • IV High 263.19% on 04/08/24
  • IV Low 8.61% on 01/05/24
  • Put/Call Vol Ratio 3.00
  • Today's Volume 8
  • Volume Avg (30-Day) 103
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 1,986
  • Open Int (30-Day) 1,845

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.13 +2.24%
on 04/11/24
4.02 -20.40%
on 03/27/24
-0.32 (-9.09%)
since 03/15/24
3-Month
2.61 +22.61%
on 01/19/24
5.38 -40.52%
on 02/20/24
+0.48 (+17.65%)
since 01/12/24
52-Week
1.79 +78.77%
on 11/10/23
5.38 -40.52%
on 02/20/24
-1.85 (-36.63%)
since 04/14/23

Most Recent Stories

More News
Idexx Laboratories (IDXX) Q1 Earnings and Revenues Beat Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 7.14% and 1.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

IDXX : 491.29 (-1.31%)
SRTS : 3.20 (-5.33%)
Integer (ITGR) Surpasses Q1 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of 6.10% and 7.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ITGR : 118.65 (+2.49%)
SRTS : 3.20 (-5.33%)
Implied Volatility Surging for Sensus Healthcare (SRTS) Stock Options

Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.

SRTS : 3.20 (-5.33%)
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -34.62% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

SRTS : 3.20 (-5.33%)
KRMD : 2.08 (unch)
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IDXX : 491.29 (-1.31%)
SRTS : 3.20 (-5.33%)
Does Sensus Healthcare, Inc. (SRTS) Have the Potential to Rally 81.12% as Wall Street Analysts Expect?

The mean of analysts' price targets for Sensus Healthcare, Inc. (SRTS) points to an 81.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

SRTS : 3.20 (-5.33%)
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline

Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRTS : 3.20 (-5.33%)
IDXX : 491.29 (-1.31%)
Wall Street Analysts Predict a 72.6% Upside in Sensus Healthcare, Inc. (SRTS): Here's What You Should Know

The consensus price target hints at a 72.6% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

SRTS : 3.20 (-5.33%)
How 2022's Biggest Healthcare Gainers Could Fare In 2023

Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023

SGFY : 30.49 (+0.07%)
SRTS : 3.20 (-5.33%)
HAE : 84.88 (-0.40%)
CVS : 68.96 (+0.47%)
Down 46.9% in 4 Weeks, Here's Why Sensus Healthcare, Inc. (SRTS) Looks Ripe for a Turnaround

Sensus Healthcare, Inc. (SRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts...

SRTS : 3.20 (-5.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare,...

See More

Key Turning Points

3rd Resistance Point 3.91
2nd Resistance Point 3.75
1st Resistance Point 3.48
Last Price 3.20
1st Support Level 3.05
2nd Support Level 2.89
3rd Support Level 2.62

See More

52-Week High 5.38
Fibonacci 61.8% 4.01
Fibonacci 50% 3.59
Last Price 3.20
Fibonacci 38.2% 3.16
52-Week Low 1.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar